IP Verse

Elanco Us Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Elanco Us Inc.

Patent Number:
EP2275132
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Nov 22, 2021
Patent Number:
EP3566695
Title:
Treatment Of Coccidiosis With Intramuscular Triazine Compositions
Applicant:
CEVA SANTÉ ANIMALE
Opposition Date:
May 5, 2021
Patent Number:
EP2688587
Title:
Salmonid Alphavirus Vaccine
Applicant:
INTERVET INTERNATIONAL B.V.
Opposition Date:
Apr 29, 2021
Patent Number:
EP3127551
Title:
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Apr 29, 2021
Patent Number:
EP3320919
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Feb 25, 2021
Patent Number:
EP2928454
Title:
New Treatments With Triazines
Applicant:
CEVA SANTÉ ANIMALE SA
Opposition Date:
Dec 18, 2020
Patent Number:
EP3076996
Title:
Vaccine Against Porcine Circo Virus Type 2
Applicant:
INTERVET INTERNATIONAL B.V.
Opposition Date:
Oct 14, 2020
Patent Number:
EP2928455
Title:
Treatment Of Coccidiosis With Intramuscular Triazine Compositions
Applicant:
CEVA SANTÉ ANIMALE
Opposition Date:
Jun 1, 2020
Patent Number:
EP2460820
Title:
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Jan 10, 2020
Patent Number:
EP1968630
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Oct 23, 2018

Competitors of Elanco Us Inc.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

BOEHRINGER INGELHEIM VETMEDICA, INC.

CEVA SANTÉ ANIMALE

Want to track Elanco Us Inc.?

Feel free to send us a message here and we will get back to you